Our findings indicated that MAP kinase interacting serine/threonine kinase 2 (MKNK2) and laminin beta 2 (LAMB2) gene expression levels were downregulated in response to HE4 interference in ovarian cancer cells, whereas exogenous HE4 protein supplementation reversed this effect. The gene discussed is MKNK2; the disease is ovarian carcinoma.